SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZSP, Genzyme Surgical Products -- Ignore unavailable to you. Want to Upgrade?

To: peter michaelson who wrote (14)7/9/1999 9:53:00 AM
From: jeffbas  Read Replies (1) | Respond to of 55
 
Peter, I am OK at sensing value but notoriously poor at selling. I would not count on it not dropping today. I consider the short term as unclear, with more to go probably from GENZ institutions that can't hold it. I still believe that in the intermediate term it will recover to between 2/3 and 100% of net cash ($6-9), with no value assigned to the $100 million surgical device business, $15 million Seprafilm business, or biotherapeutic R&D.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News